Risk, culture, and control
Historian Caley Horan studies commerce and uncertainty in modern American life.
Historian Caley Horan studies commerce and uncertainty in modern American life.
Bioengineer and artist David Kastner seeks to unlock the secrets of catalysis and improve science communication through eye-catching visuals.
Professor Joshua Bennett’s scholarship, poetry, and teaching help students address core questions about values and meaning in life.
Through MISTI’s Imperial College London Exchange, students experience AeroAstro, MIT, and the beauty of New England.
From scallop fishing in New Bedford to deforestation in the tropics, “our goal is to get some empirical traction on the problem,” says PhD student Aaron Berman.
To understand how everything from atoms to neutron stars behave, he says, requires “abstracting away the details to see main principles that drive everything.”
Philosophy doctoral student Abe Mathew is both studying philosophy and questioning some of its deeply-held ideas.
Bernardo Picão, a graduate student in physics, has turned to MIT Open Learning’s resources throughout his educational journey.
PhD student Xinyi Zhang is developing computational tools for analyzing cells in the age of multimodal data.
Thomas Varnish has always loved a hands-on approach to science. Research in lab-based astrophysics has enabled the PhD student to experiment in a heavily theoretical subject.
Rising superpowers like China are “cautious opportunists” in global institutions, and the U.S. should avoid overreaction, PhD student Raymond Wang argues.
The Chan siblings reflect on their Motorsports experience, eight years apart.
The senior program and technical associate for the Community Services Office has been a supporter of the MIT community since he arrived on campus as a student.
Through academia and industry, Gevorg Grigoryan PhD ’07 says there is no right path — just the path that works for you.
By designing new tools that can analyze huge libraries of immune cells and their targets, Michael Birnbaum hopes to generate better T cell therapies for cancer and other diseases.